Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Abbott will collaborate with Nippon Shinyaku on development of incontinence Rx

Oct. 14, 1998

Fujisawa withdraws NDA for vamicamide

Oct. 1, 1998

PSA is a useful indicator of prostate cancer in finasteride-treated patients

Sep. 21, 1998

Preliminary analysis indicates good efficacy and safety of resiniferatoxin in urge incontinence

Sep. 18, 1998

New bladder-selective M3 antagonist from Yamanouchi for urinary urge incontinence

Sep. 18, 1998

New treatment for BPH discovered by Hungarian research team

Sep. 17, 1998

Bioniche receives EU registration for Cystistat

Sep. 16, 1998

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

New agent for unstable bladder introduced in U.K.

Sep. 11, 1998

WAY-140288: a follow-up V2 antagonist and aquaretic agent from Wyeth-Ayerst

Aug. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...